Twitxy Saved

Christian Soschner

Verified account This account is verified. Learn more

@Soschner

Deep Tech Board Advisor | Capital, Valuation & AI Business Model Change | Host, Beginner’s Mind 🎙️ | Scaling, leadership, investing & books
Vienna cslifescienceinvest.com/news/ Joined March 2012
3.3K Following 2K Followers 27K Posts

Latest posts 5

Pinned post

Christian Soschner Verified account @Soschner
“This has been on my mind for weeks.”

Most of my sessions start with that sentence. A board meeting in March. A round that has to close. A partner to approach first.

The question is clear. The calendar is full. And one good conversation fades by Thursday.

Research on patient memory puts a number on it: people forget between 40 and 80 percent of what their doctor tells them as soon as the visit ends.

Advice fades the same way.

For that reason my sessions run in three steps:

Prepare. You write down your goal, why it matters and the questions you want answered. Writing shows the open points before we meet.
Session. Sixty minutes on your decision, ending with one step and a date, written as “if this happens, then I do that.”
De-brief. Within 24 hours, in writing, with the recording and the transcript.

Today I published the handbook behind it: every step, six exercises from my toolbox and the research behind each part.

It is free. No email form.

The link to the article and the download is in the first comment.

What decision has been on your mind for weeks?
Christian Soschner Verified account @Soschner
Anthropic lost $104 billion in nine months. Its operations brought in $6.6 billion in cash.

ANT starts trading on Nasdaq today at $83. Five facts from the S-1 most buyers will overlook:

1. The loss. $94.3 billion of it comes from revaluing convertible notes. Look at the cash flow from operations. It is the number that is hardest to fake.

2. The fund. Anthropic issued 5% of its fully diluted shares to a public benefit fund, and every 50% rise in the share price can send up to 2% more.

3. The control. Public shares get under half of the vote. One trust share elects 4 of 7 directors.

4. The compute bill. Anthropic has committed $900.9 billion to compute, and its biggest suppliers own the stock. A shareholder that pulls the trigger on Anthropic hurts itself.

5. The customers. Nine of the ten largest pharma companies in the Fortune 500 pay Anthropic. Pharma is hard to get into and lies outside the tech ecosystem. These are real buyers.

One more thing: 7.4% of the company trades, insiders can sell from day one, and Bloomberg expects Nasdaq-100 funds to buy on 21 December.

All five with charts and sources:
cslifescienceinvest.com/articles/anthr…
Christian Soschner Verified account @Soschner
Nvidia doubled its revenue to $115.8 billion in one year. Its biggest risk does not show up anywhere in the report.

Five findings from Q3 fiscal 2027:

1. Growth. Revenue up 103%. The Q4 guide of $130 billion beats the $125.1 billion consensus.

2. Customers. AI clouds, industrial and enterprise customers now bring in 44% of data center revenue, up from 31% a year ago.

3. Product. Vera Rubin brought in close to $20 billion in its first quarter. That is more than all of Nvidia earned in the quarter to October 2023.

4. Cash. Free cash flow doubled in one quarter to $43.8 billion. Supply commitments rose to $390 billion, most of it multi-year memory. Demand is strong when buyers reserve capacity years into the future. That is a sellers' market.

5. Drug development. Isomorphic Labs raised $5 billion, the largest venture round in biotech history, and Nvidia is not among its investors. Money of this size buys compute, and compute needs chips. Eli Lilly bought its own AI factory with 1,016 Nvidia GPUs.

The real question is the culture. Jensen Huang built a company that out-innovates every competitor and pulls in the best talent. That culture is the moat, even at this scale. Apple had years: Steve Jobs prepared Tim Cook to keep Apple's culture alive. Nvidia has to make that move now.

The numbers are strong. They are the look in the rearview mirror.

All five charts in the full article:
cslifescienceinvest.com/articles/nvidi…